I remember it differently. The price tanked before ASH last year with a lot of concerns over the anemia benefit. Once the results were presented at ASH, the stock was up to 2.00 in After Hours. Not bad considering it got down to $1.03 a week or so earlier. Then there was a gradual increase to about $2.35 in February, before the dilution.
been quite a few years ago, but remember broker really pumped on ymi, trial results not good stock dropped like 70% . I have bought and sold shares since then, still waiting on something good to happen, not good stragey but betting on come. last bio tech i will own
I hear you Ishaver9. Last Biotech for me too. But, it's worth the odds in favor for the multiple gain we'll appreciate. We are better than 50/50 and beats playing blackjack in Las Vegas. Wait a minute. Maybe I'm wrong. This doesn't beat playing blackjack in Las Vegas.